Filing Details
- Accession Number:
- 0001171843-15-000934
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-19 16:05:44
- Reporting Period:
- 2015-02-18
- Filing Date:
- 2015-02-19
- Accepted Time:
- 2015-02-19 16:05:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234712 | Joseph Bonaccorsi | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-18 | 7,500 | $1.46 | 319,189 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-02-18 | 92,500 | $1.46 | 411,689 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-18 | 40,827 | $47.33 | 370,862 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-02-18 | 7,500 | $0.00 | 7,500 | $1.46 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-02-18 | 92,500 | $0.00 | 92,500 | $1.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
92,500 | 2015-02-22 | No | 4 | M | Direct | |
0 | 2015-02-22 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2014.
- Upon execution of transactions disclosed on this Form 4, all securities subject to the 10b5-1 trading plan have been transacted and the plan has expired pursuant to its terms.
- All proceeds from the sale were used to cover exercise price and taxes due upon exercise of options.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $46.80 to $48.49 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Amount of Shares Beneficially Owned Following Reported Transaction includes 104,414 unvested shares subject to a restricted stock awards and 266,448 shares owned outright. Shares owned outright include 1,015 shares acquired through participation in the Employee Stock Purchase Plan for the 2014 plan year.
- The option vested in three annual installments with 33,333 options vesting on each of February 22, 2011 and February 22, 2012, and 33,334 options vesting on February 22, 2013.
- Exercise of stock options that were approaching their 5-year expiration date.
- There was no consideration given in exchange for the security.